Aziyo Biologics, Inc. announced the appointment of Ronald (Ron) Lloyd as President and Chief Executive Officer of the company. Mr. Lloyd will be based in the Silver Spring, Maryland office with responsibility for all aspects of the Aziyo organization. He will also become a member of the Company's Board of Directors.

Mr. Lloyd most recently served as Executive Vice President and President of Hospital Therapies for Mallinckrodt Pharmaceuticals. Prior to Mallinckrodt, Mr. Lloyd was with Baxter Healthcare where he held the positions of President of Immunology, General Manager, BioScience and Vice President, Global Marketing for the BioScience Division.